Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis.
Shay MenascuMichal Siegel-KirshenbaumSapir Dreyer-AlsterYehuda WarszawerDavid MagalashviliMark DolevMathilda MandelGil HarariAnat AchironPublished in: Multiple sclerosis journal - experimental, translational and clinical (2023)
IVIg treatment proved efficient to reduce the rate and severity of relapses during pregnancy and the three-month post-partum.